HANGZHOU SUNSTONE TECHNOLOGY CO.,LTD
China
Manufacturer/ Producer
Our company engaged the research, develope and produce the absorbable ligating clip and applicator.the ligation system include the absorbable ligating clip and the applier is used in endoscopic surgery for the purpose ligating tubular organization such like blood vessel and cystic duct.The clip compare to metal clip and plastic v-type clip show great advantages such like no x-ray image effection, fully absorbable in vivo and so on.
Website
Manufacturer/ Producer
Weilei Industrial Zone,Hefeng village
ingwei town,Xiaoshan District
311215 Hangzhou - China
Company info
Key figures
-
- Company headcount
- 11 – 50
-
- Sales staff
- 1 – 10
-
- % of export sales
- 30%
Organisation
-
- Year established
- 2005
-
- pages.epage-home.site-status
- Registered office – Parent company
-
- Main activity
- Manufacturer/ Producer
Business info
Trading areas
- International
Payment methods
- Bill of exchange
- Telex transfer
- Swift transfer
- Stand-by letter of credit
- Cash on delivery
Delivery areas
Terms of delivery (incoterms)
- Purchaser
- Shared
- Vendor
Activities of HANGZHOU SUNSTONE TECHNOLOGY CO.,LTD
- Medical and surgical instruments
- ligating clip
- titanium clip
europages also recommends
A selection of companies related to the activity:
A selection of products that might interest you
MPS MICRO PRECISION SYSTEMS AG
Switzerland
Novostia, a Swiss startup founded in 2017, has entrusted MPS with the manufacture of its TRIFLO artificial valve, a revolutionary aortic prosthesis on several levels. Thanks to its aerodynamic design, the presence of three leaflets and the absence of physical pivot axes for the leaflets, the TRIFLO valve aims to satisfy the following three criteria: - A device lifespan at least equal to that of the patient, to avoid the need for a second surgical procedure. This means more than 30 million flap openings and closures per year, with no leaks, blockages, cracks, ruptures or flap escapes. - The artificial valve must not lead to thrombosis, so that patients do not need to take anticoagulants. - Operation (flap opening and closing, blood flow through the valve) must be as silent as possible, so as not to disturb the patient or those around him, day or night. The TRIFLO device is in clinical trial and is not approved for sale.
Request for quotes
Create one request and get multiple quotes form verified suppliers.
- Only relevant suppliers
- Data privacy compliant
- 100% free